Company profile
Shoulder Innovations, Inc.
NYSE: SI · Healthcare · Medical - Specialties
PublicHQ Grand Rapids, CACIK 0001699350Reports USD
#441 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
42DFH 67DQ 5GM —SS 45
v0.1 · 55/100 weight · provisional
↑ Altman-Z, balance-sheet leverage · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$53.9M
Rev growth YoY (TTM)
+55.9%
Net income (FY)
-$40.4M
Employees
74
as of 2026-08-12
Market cap
$407.1M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$47.3M$47.3M2025
Net income-$40.4M-$40.4M2025
Operating income-$26.3M-$26.3M2025
Total assets$169.9M$169.9M2025
Liabilities$29.2M$29.2M2025
Equity$140.8M$140.8M2025
Revenue by segment
Filed disclosures · FY2025
By product
Reportable100%
By geography
Not disclosed.
The read
What is Shoulder Innovations, Inc.’s revenue?
Shoulder Innovations, Inc. booked $47.3M in FY2025 revenue, growing 50% year over year — faster than most Healthcare companies we track, at a -85.3% net margin.
Peers · Healthcare
Lexicon Pharmaceuticals, Inc.59CBioqual, Inc.65BGossamer Bio, Inc.24DEvome Medical Technologies Inc.——Protagonist Therapeutics, Inc.57CSepterna Inc50DKey facts
CEORobert Joseph Ball
SectorHealthcare
IndustryMedical - Specialties
HeadquartersGrand Rapids, CA
ExchangeNYSE: SI
Employees74
IPO date2025-07-31
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.